EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The gut-lung axis in tuberculosis: A new frontier in immunomodulation and microbiota-directed therapeutic strategies

Divya Nasare, Shashikant Bagade

Microbial Pathogenesis · 2025-12 · 209 · 108087

DOI: 10.1016/j.micpath.2025.108087 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2025-12. Verfasst von Divya Nasare und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Mana…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lung, Immunomodulation, Tuberculosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 203 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLungImmunomodulationTuberculosisHumansDysbiosisMycobacterium tuberculosisProbioticsFecal Microbiota TransplantationPrebioticsAnimals

Stichwörter der Autor:innen

Host-directed therapiesImmunological interplayPersonalized microbiota therapiesThe gut-lung axisTuberculosis

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-be University, V.L. Mehta Road, Vile…
  • Department of Pharmaceutical Chemistry, School of Pharmacy & Technology Management, SVKM's Narsee Monjee Institute of Management Studies, Shirpur, Maharashtra, 425405, India. Electronic address: shashikant.bagade@nmims.…

Zitieren

APA

Nasare, D., & Bagade, S. (2025). The gut-lung axis in tuberculosis: A new frontier in immunomodulation and microbiota-directed therapeutic strategies. Microbial Pathogenesis, 209, 108087. https://doi.org/10.1016/j.micpath.2025.108087

Vancouver

Nasare D, Bagade S. The gut-lung axis in tuberculosis: A new frontier in immunomodulation and microbiota-directed therapeutic strategies. Microbial Pathogenesis. 2025;209:108087. doi:10.1016/j.micpath.2025.108087

BibTeX
@article{Nasare2025,
  author = {Nasare, Divya and Bagade, Shashikant},
  title = {The gut-lung axis in tuberculosis: A new frontier in immunomodulation and microbiota-directed therapeutic strategies},
  journal = {Microbial Pathogenesis},
  year = {2025},
  volume = {209},
  pages = {108087},
  doi = {10.1016/j.micpath.2025.108087}
}
Kostenlos starten →